India’s Largest Drugmaker, Sun Pharma, to Buy U.S. Firm Organon in $11.75 Billion Deal
By Priyanka Salve
Shares in Sun Pharmaceutical Industries rose more than 7% Monday, after India’s largest drugmaker announced it will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion, including debt.
Photo courtesy of psyberartist via Flickr.
Source: CNBC (link opens in a new window)
- Categories
- Health Care
